This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Andreas-David Brunner
Introduction
Andreas-David Brunner is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies.
Latest Patents
Brunner holds a patent titled "Antibodies to Connective Tissue Growth Factor (CTGF) and Uses Thereof." This patent reflects his innovative approach to addressing medical challenges through the use of antibodies.
Career Highlights
Brunner is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on groundbreaking research and development in the field of biotechnology.
Collaborations
Brunner collaborates with Lars Dittus, a fellow researcher, to advance their projects and share insights in their respective areas of expertise.
Conclusion
Andreas-David Brunner's contributions to biotechnology through his patent and work at Boehringer Ingelheim International GmbH highlight his role as an influential inventor in the industry.